N-Desmethyl imatinib-d8

• CAT Number: S000914
• CAS Number: 1185103-28-9
• Molecular Formula: C28H21D8N7O
• Molecular Weight: 487.63
• Purity: ≥95%
• Target: Drug Metabolite
• IUPAC Name: N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]-4-[(2,2,3,3,5,5,6,6-octadeuteriopiperazin-1-yl)methyl]benzamide
• InChI: InChI=1S/C28H29N7O/c1-20-4-9-24(17-26(20)34-28-31-12-10-25(33-28)23-3-2-11-30-18-23)32-27(36)22-7-5-21(6-8-22)19-35-15-13-29-14-16-35/h2-12,17-18,29H,13-16,19H2,1H3,(H,32,36)(H,31,33,34)/i13D2,14D2,15D2,16D2
• InChIKey: BQQYXPHRXIZMDM-DBVREXLBSA-N
• SMILES: [2H]C1(C(N(C(C(N1)([2H])[2H])([2H])[2H])CC2=CC=C(C=C2)C(=O)NC3=CC(=C(C=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5)([2H])[2H])[2H]

N-Desmethyl Imatinib-d8 is a high-purity deuterated compound designed for advanced pharmaceutical and biochemical research. This isotopically labeled version of N-Desmethyl Imatinib, featuring eight deuterium atoms, is crucial for studies involving cancer therapeutics, pharmacokinetics, and metabolic pathway analysis. Its stable isotope labeling ensures precise and reliable analytical results. With enhanced stability and consistency, it is suitable for various experimental setups. Ideal for oncology research and drug development, N-Desmethyl Imatinib-d8 integrates seamlessly into existing protocols, offering a robust and cost-effective solution for high-precision scientific investigations.